Fireside Chat Webinar

Fireside Chat Webinar

Hosted Live | 7 Feb 2023

Bob Proulx, Imagion’s CEO, and Dr. Yalia Jayalakshmi, Chief Development Officer discussed the latest positive independent review of our MagSense® HER2 imaging agent including what this means for Imagion Biosystems; how this accelerates our path to market; an update on the future of our technology; and fielded questions from attendees in a Q&A session.

Questions? Email us: investor@imagionbio.com

Interested to learn more information about our independent review and path to market?

Read More of Our Latest News

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.